Literature DB >> 11881243

[Compression dressing after hip joint replacement reduces the need of allogeneic blood transfusion].

Irene Hörnberg1, Anders Bengtsson, Bo Bergman.   

Abstract

Allogeneic blood transfusion may increase the risk for postoperative infections, allergic reactions and transmission of diseases. The aim with the present study was to evaluate the effect on blood saving with a new type of compression dressing after hip joint replacement surgery. 50 patients undergoing after hip joint replacement surgery were prospectively allocated to postoperatively get a standard dressing (n = 24) or the new type of a compression dressing (n = 26). The peroperative bleeding was similar in both groups. The need for allogeneic blood transfusions were significantly higher in the group of patients that got standard dressing. This study indicates that the compression dressing reduces the need for allogeneic blood transfusions after after hip joint replacement surgery.

Entities:  

Mesh:

Year:  2002        PMID: 11881243

Source DB:  PubMed          Journal:  Lakartidningen        ISSN: 0023-7205


  3 in total

1.  The efficacy of continuous-flow cryo and cyclic compression therapy after hip fracture surgery on postoperative pain: design of a prospective, open-label, parallel, multicenter, randomized controlled, clinical trial.

Authors:  Nick C Leegwater; Peter A Nolte; Niels de Korte; Martin J Heetveld; Kees J Kalisvaart; Casper P Schönhuth; Bas Pijnenburg; Bart J Burger; Kees-Jan Ponsen; Frank W Bloemers; Andrea B Maier; Barend J van Royen
Journal:  BMC Musculoskelet Disord       Date:  2016-04-08       Impact factor: 2.362

2.  Pneumatic wound compression after hip fracture surgery.

Authors:  Torsten Johansson
Journal:  Acta Orthop       Date:  2009-10       Impact factor: 3.717

3.  Pneumatic wound compression after hip fracture surgery did not reduce postoperative blood transfusion: A randomized controlled trial involving 292 fractures.

Authors:  Anna Apelqvist; Markus Waldén; Gert-Uno Larsson; Isam Atroshi
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.